ClinVar Miner

Submissions for variant NM_014049.5(ACAD9):c.-44_-41dup

gnomAD frequency: 0.04863  dbSNP: rs387906242
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000001073 SCV000440750 likely benign Acyl-CoA dehydrogenase 9 deficiency 2016-06-14 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000201519 SCV001437357 uncertain significance not specified 2020-09-23 criteria provided, single submitter clinical testing Variant summary: ACAD9 c.-44_-41dupTAAG is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.039 in 280626 control chromosomes in the gnomAD database, including 475 homozygotes. The observed variant frequency is approximately 35 fold of the estimated maximal expected allele frequency for a pathogenic variant in ACAD9 causing Mitochondrial Complex I Deficiency, Nuclear Type 20 phenotype (0.0011), strongly suggesting that the variant is benign. c.-44_-41dupTAAG has been reported in the literature in one individual affected with Acyl-Coenzyme dehydrogenase 9 deficiency (He_2007). The report does not provide unequivocal conclusions about association of the variant with Mitochondrial Complex I Deficiency, Nuclear Type 20. He_2007 reports this variant results in a transcriptional defect from patients liver sample and 75% reduction of expression of a reporter gene. One ClinVar submitter (evaluation after 2014) cites the variant as likely benign. Although the allele frequency of this variant suggests it may be benign, the possibility of it being a common low-penetrant pathogenic variant cannot be ruled out. Therefore, this variant was classified as VUS-possibly benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV001515971 SCV001724163 benign not provided 2023-12-18 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000001073 SCV001737179 likely benign Acyl-CoA dehydrogenase 9 deficiency 2021-05-18 criteria provided, single submitter clinical testing
GeneDx RCV001515971 SCV001903705 benign not provided 2018-10-05 criteria provided, single submitter clinical testing
OMIM RCV000001073 SCV000021223 pathogenic Acyl-CoA dehydrogenase 9 deficiency 2007-07-01 flagged submission literature only
Natera, Inc. RCV000001073 SCV001461494 benign Acyl-CoA dehydrogenase 9 deficiency 2020-09-16 no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000201519 SCV001741580 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV001515971 SCV001932621 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.